视窗
×
loading...
Your position:www.healthoo.com >> EN >> EN >> Formulation >> The first in the world! Huadong Pharmaceuticals new FRα target ADC was approved by the FDA >> article
 
The first in the world! Huadong Pharmaceuticals new FRα target ADC was approved by the FDA
Editor:xuezhe    Clicks:52    Date:2022-11-17 17:21:31
Keyword: FDA
Healthoo Information:
The first in the world! Huadong Pharmaceuticals new FRα target ADC was approved by the FDA
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName 
Contact:  Title: Mr.Ms.
Password  
Repeat password: 
Mobile 
Email 
Verification code: 
Company Name 
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • FDA Success Stories CDE Recommendations: How MIDD Accelerates Drug Dis...
  • The worlds first Upadatinib extended-release tablets approved by FDA f...
  • Sodium thiosulfate has been approved by the FDA to reduce hearing loss...
  • FDA approves ibrutinib for chronic graft-versus-host disease in childr...
  • FDA Issues Drug Statement, Mercks Hypoglycemic Drug Sitagliptin Detect...
  • Upadatinibs launch accelerated: Crohns disease has simultaneously subm...
  • FDA Breakthrough Therapy Designation for Topical Vitamin A Derivatives...
  • AstraZenecas Ultomiris Third Indication Approved by US FDA!
  • New Drugs Approved by FDA in February 2022
  • Nature: FDA Approval of New Drugs Sales Forecast in 2021
    • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463